Cargando…
RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38
Significant advances have been made in the development of small molecules blocking the p53/MDM2 interaction. The Mdm2 inhibitor Nutlin-3 is restricted to tumors carrying wtp53. In contrast, RITA, a compound that binds p53, has recently been shown also to restore transcriptional functions of mtp53. A...
Autores principales: | Weilbacher, A, Gutekunst, M, Oren, M, Aulitzky, W E, van der Kuip, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123078/ https://www.ncbi.nlm.nih.gov/pubmed/25010984 http://dx.doi.org/10.1038/cddis.2014.284 |
Ejemplares similares
-
p53 Hypersensitivity Is the Predominant Mechanism of the Unique
Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to
Cisplatin
por: Gutekunst, Matthias, et al.
Publicado: (2011) -
RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53(abnormal) myeloma cells independently of the p53 pathway
por: Surget, Sylvanie, et al.
Publicado: (2014) -
Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents
por: Michaelis, M, et al.
Publicado: (2012) -
Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma
por: Saha, Manujendra N., et al.
Publicado: (2012) -
Decreased DNA Damage and Improved p53 Specificity of RITA Analogs
por: Zhan, Yue, et al.
Publicado: (2022)